Axsome Therapeutics shares owned by Bellevue Group
Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Bellevue Group
from 13F filings
Historical chart of Bellevue Group investment in Axsome Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Axsome Therapeutics held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Axsome Therapeutics by Bellevue Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $6.4M | 52k | 121.45 |
| 2025-06-30 | $5.9M | 56k | 104.39 |
| 2025-03-31 | $11M | 96k | 116.63 |
| 2024-12-31 | $10M | 119k | 84.61 |
| 2024-09-30 | $33M | 367k | 89.87 |
| 2024-06-30 | $42M | 517k | 80.50 |
| 2024-03-31 | $55M | 686k | 79.80 |
| 2023-12-31 | $51M | 635k | 79.59 |
| 2023-09-30 | $44M | 632k | 69.89 |
| 2023-06-30 | $41M | 574k | 71.86 |
| 2023-03-31 | $27M | 441k | 61.68 |
| 2022-12-31 | $34M | 437k | 77.13 |
| 2022-09-30 | $22M | 497k | 44.62 |
| 2022-06-30 | $31M | 817k | 38.30 |
| 2022-03-31 | $30M | 720k | 41.39 |
| 2021-12-31 | $25M | 652k | 37.78 |
| 2021-09-30 | $25M | 753k | 32.96 |
| 2021-06-30 | $24M | 352k | 67.46 |